These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 25347557)

  • 1. Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1.
    Salis O; Bedir A; Gulten S; Okuyucu A; Kulcu C; Alacam H
    Cancer Biother Radiopharm; 2014 Nov; 29(9):368-75. PubMed ID: 25347557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line.
    Salis O; Bedir A; Ozdemir T; Okuyucu A; Alacam H
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1602-9. PubMed ID: 24943970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes.
    Salis O; Okuyucu A; Bedir A; Gör U; Kulcu C; Yenen E; Kılıç N
    Tumour Biol; 2016 Mar; 37(3):3017-24. PubMed ID: 26419593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway.
    Zhang L; Liu J; Liu Y; Xu Y; Zhao X; Qian J; Sun B; Xing C
    Clin Exp Nephrol; 2015 Jun; 19(3):336-42. PubMed ID: 24942605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
    Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
    Kotamraju S; Williams CL; Kalyanaraman B
    Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin.
    Wang X; Luo C; Liu J; Zhang C; Wang Y; Zhu Z
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):651-4. PubMed ID: 16696316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticancer effects of desferrioxamine on human breast adenocarcinoma and hepatocellular carcinoma cells.
    Salis O; Bedir A; Kilinc V; Alacam H; Gulten S; Okuyucu A
    Cancer Biomark; 2014; 14(6):419-26. PubMed ID: 25335733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Na+/Ca2+ exchanger by fluvastatin in rat cardiomyoblast H9c2 cells: involvement of RhoB in Na+/Ca2+ exchanger mRNA stability.
    Maeda S; Matsuoka I; Iwamoto T; Kurose H; Kimura J
    Mol Pharmacol; 2005 Aug; 68(2):414-20. PubMed ID: 15879517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.
    Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ
    Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
    Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
    Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against monocrotaline-induced pulmonary arterial hypertension and caveolin-1 downregulation by fluvastatin in rats.
    Zhu S; Wang J; Wang X; Zhao J
    Mol Med Rep; 2018 Mar; 17(3):3944-3950. PubMed ID: 29286128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
    Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
    Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia.
    Matschke J; Wiebeck E; Hurst S; Rudner J; Jendrossek V
    Radiat Oncol; 2016 Jun; 11():75. PubMed ID: 27251632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.